Clinical Laboratory Tests Industry Overview
The global clinical laboratory tests market size was valued at USD 176.7 billion in 2019. It is expected to register a CAGR of 7.1% over the forecast period.
Increasing prevalence of chronic diseases and rising awareness among health-conscious population have fueled the growth of the overall market. The demand for clinical laboratory tests is driven by growing investments in diagnosing target diseases such as cardiovascular disorders, tuberculosis, and diabetes. Clinical laboratory tests help diagnose diabetes mellitus. According to an article published by the International Diabetes Federation in 2019, around 463 million adults were living with diabetes, and by 2045 it is estimated to reach 700 million globally.
Gather more insights about the market drivers, restrains and growth of the Global Clinical Laboratory Tests Market
Increasing geriatric population is anticipated to drive the overall market for clinical laboratory tests. According to the data published by the World Population Prospects: the 2019 Revision, around one in 11 people were aged over 65 years in 2019, and by 2050, it is estimated that approximately one in 6 people in the world will be aged 65 years and above. Clinical laboratory tests are increasingly used to diagnose age-related diseases.
Moreover, growing rate of insufficient exercise, consumption of unhealthy food, and the subsequent rise in cases of obesity are expected to increase the prevalence of various chronic diseases. Rising awareness of the necessity of regular body profiling among healthcare professionals and patients globally is expected to increase the demand for clinical laboratory tests.
Browse through Grand View Research’s Clinical Diagnostics Industry Research Reports..
- In Vitro Diagnostics Market – The global in vitro diagnostic market size was valued at USD 111.67 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 0.2% from 2022 to 2030. The growth can be attributed to the increasing adoption of IVDowing to the rise in testing due to the pandemic.
- Point Of Care Diagnostics Market – The global point of care diagnostics market size was valued at USD 37.03 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030.
Clinical Laboratory Tests Market Segmentation
Grand View Research has segmented the global clinical laboratory tests market on the basis of type, end use, and region.
Clinical Laboratory Tests Type Outlook (Revenue, USD Billion, 2016 – 2027)
- Complete blood count
- HGB/HCT
- Basic metabolic panel
- BUN creatinine tests
- Electrolytes testing
- HbA1c tests
- Comprehensive metabolic panel
- Liver panel
- Hepatitis
- Bile duct obstruction
- Liver Cirrhosis
- Liver Cancer
- Bone disease
- Autoimmune disorders
- Others
- Renal panel
- Lipid panel
Clinical Laboratory Tests End-use Outlook (Revenue, USD Billion, 2016 – 2027)
- Central Laboratories
- Complete blood count
- HGB/HCT
- Basic metabolic panel
- BUN creatinine tests
- Electrolytes testing
- HbA1c tests
- Comprehensive metabolic panel
- Liver panel
- Renal panel
- Lipid panel
- Primary Clinics
- Complete blood count
- HGB/HCT
- Basic metabolic panel
- BUN creatinine tests
- Electrolytes testing
- HbA1c tests
- Comprehensive metabolic panel
- Liver panel
- Renal panel
- Lipid panel
Clinical Laboratory Tests Regional Outlook (Revenue, USD Billion, 2016 – 2027)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Market Share Insights
- November 2019: QIAGEN entered into a strategic agreement with Laboratory Corporation of America Holdings to extend its existing QIAGEN Clinical Insights license.
- August 2018: QIAGEN collaborated with SRL, Inc., Japan’s largest clinical testing lab company, to prepare for the introduction of novel companion diagnostic tests along with new drug approvals.
Key Companies profiled:
Some prominent players in the global clinical laboratory tests market include
- Abbott
- ARUP Laboratories
- OPKO Health, Inc.
- Bioscientia Institut für Medizinische Diagnostik GmbH
- Charles River
- NeoGenomics Laboratories, Inc.
- Genoptix, Inc.; Healthscope Ltd.
- Labco
- Laboratory Corporation of America Holdings (LabCorp)
- Fresenius Medical Care
- QIAGEN
- Quest Diagnostics
- Siemens Healthcare Private Limited
- Tulip Diagnostics (P) Ltd.
- Sonic Healthcare; Merck KgaA
- Biosino Bio-technology
- Science Inc.
Order a free sample PDF of the Clinical Laboratory Tests Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
